Additional Listing - Amendment

14 October 2011

Dechra Pharmaceuticals PLC (the "Company")

Blocklisting

On 12 October, the Company announced that it had made an application to the UK Listing Authority and the London Stock Exchange for admission to (i) the Official List and (ii) to trading on the London Stock Exchange's markets for a blocklisting of securities in respect of 320,000 Ordinary Shares of 1p each ("New Ordinary Shares") (RNS number: 0814Q).

The announcement stated that the New Ordinary Shares, would rank pari passu in all respects with the existing ordinary shares in issue, but erroneously stated that they were to be issued in connection with the Approved Share Option Scheme. The New Ordinary Shares will in fact be issued in connection with the SAYE, Unapproved Share Option and LTIP Schemes. It is still expected that admission will become effective on 18 October 2011.

The full text of the amended announcement is printed below:

Blocklisting

Application has been made to the UK Listing Authority and the London Stock Exchange for admission to (i) the Official List and (ii) to trading on the London Stock Exchange's markets for a blocklisting of securities in respect of 320,000 Ordinary Shares of 1p each ("New Ordinary Shares").

The New Ordinary Shares, which will rank pari passu in all respects with the existing ordinary shares in issue, are being issued in connection with the SAYE, Unapproved Share Option and LTIP Schemes. It is expected that admission will become effective on 18 October 2011.

Enquiries:

Zoe Goulding, Company Secretary

Telephone number: 01782 771100